Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric prospective cohortPauline Tétu, Célèste Lebbé, Clara Allayous et al.|European Journal of Cancer|2019Cited by 35
Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case–control studyLéo Plaçais, Célèste Lebbé, Sabiha Trabelsi et al.|Annals of the Rheumatic Diseases|2022Cited by 34
Quality‐of‐life assessment in French patients with metastatic melanoma in real lifeM. Kandel, Isabelle Borget, Stéphane Dalle et al.|Cancer|2019Cited by 14
Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National CohortManon Girod, O. Dereure, Stéphane Dalle et al.|JCO Precision Oncology|2022Cited by 14
Association of Time From Primary Diagnosis to First Distant Relapse of Metastatic Melanoma With Progression of Disease and SurvivalA. Vallet, Bastien Oriano, Laurent Mortier et al.|JAMA Dermatology|2019Cited by 10